ArticleTherapeutic advances in medical oncology2024
Patient perspectives on treatment-related toxicities and therapeutic drug monitoring with tyrosine kinase inhibitors for the treatment of non-small-cell lung cancer.
Judith Gulikers et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.